Omep



Indications and Reactions:

Role Indications Reactions
Primary
Dyspepsia 16.7%
Gastritis 16.7%
Gastrooesophageal Reflux Disease 16.7%
Hyperthyroidism 16.7%
Osteoporosis 16.7%
Tachycardia 16.7%
Diarrhoea 20.0%
Eye Haemorrhage 20.0%
Pain In Extremity 20.0%
Tinnitus 20.0%
Yellow Skin 20.0%
Secondary
Pain 15.5%
Hypertension 9.7%
Multiple Drug Overdose 6.8%
Thrombosis Prophylaxis 6.8%
Osteoporosis 5.8%
Drug Use For Unknown Indication 4.9%
Prophylaxis Against Gastrointestinal Ulcer 4.9%
Pruritus 4.9%
Constipation 3.9%
Diabetic Neuropathy 3.9%
Nausea 3.9%
Procedural Pain 3.9%
Sedation 3.9%
Skin Reaction 3.9%
Urinary Tract Infection 3.9%
Cerebral Infarction 2.9%
Endocarditis 2.9%
Prophylaxis 2.9%
Toxoplasmosis 2.9%
Anaemia 1.9%
Stevens-johnson Syndrome 22.2%
Intentional Overdose 16.7%
Nausea 16.7%
Medication Error 5.6%
Pancreatitis 5.6%
Sepsis 5.6%
Sinus Bradycardia 5.6%
Stomach Discomfort 5.6%
Suicide Attempt 5.6%
Toxic Epidermal Necrolysis 5.6%
Weight Decreased 5.6%
Concomitant
Product Used For Unknown Indication 31.1%
Hypertension 17.1%
Drug Use For Unknown Indication 15.4%
Pain 4.7%
Rheumatoid Arthritis 4.3%
Atrial Fibrillation 2.9%
Prophylaxis 2.3%
Renal Transplant 2.3%
Chronic Obstructive Pulmonary Disease 2.1%
Hodgkin's Disease 2.1%
Depression 2.0%
Gastritis 1.9%
Osteoporosis 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Diabetes Mellitus 1.6%
Nausea 1.5%
Diffuse Large B-cell Lymphoma 1.3%
Type 2 Diabetes Mellitus 1.3%
Hypercholesterolaemia 1.2%
Hyperuricaemia 1.2%
Vomiting 12.6%
Syncope 10.5%
Thrombocytopenia 8.4%
Pneumonia 7.4%
Hyposmia 5.3%
Renal Failure Acute 5.3%
Ventricular Fibrillation 5.3%
Gamma-glutamyltransferase Increased 4.2%
Gastrointestinal Haemorrhage 4.2%
Pancreatitis 4.2%
Weight Decreased 4.2%
Death 3.2%
Diabetes Mellitus Inadequate Control 3.2%
Paraesthesia 3.2%
Pleurisy 3.2%
Prostate Cancer 3.2%
Pulmonary Oedema 3.2%
Rectal Haemorrhage 3.2%
Renal Failure 3.2%
Urinary Retention 3.2%
Interacting
Renal Failure Chronic 25.0%
Heart Transplant 16.7%
Hypertension 16.7%
Muscle Tightness 16.7%
Dyslipidaemia 8.3%
Ischaemic Heart Disease Prophylaxis 8.3%
Prophylaxis Against Gastrointestinal Ulcer 8.3%
Upper Respiratory Tract Infection 100.0%